ASPET Discovery Health Professions
Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia
The publisher did not provide an abstract — full text is available via the link below.